|
Market Closed -
OTC Markets
21:55:52 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.820 USD | +3.75% |
|
0.00% | -17.78% |
| 08-12 | HLS Therapeutics Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | HLS Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLS THERAPEUTICS INC. | Pharmaceuticals Wholesale | +3.75% | 0.00% | -17.78% | -26.37% | -80.60% | 86.34M |
-
|
-
|
-
|
- Stock Market
- Stocks
- HLS Stock
- HLTRF Stock
- Charts HLS Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
